SEC
Filing

SEC Filing Details

Document Details

Filing Date
Feb 9, 2009
Document Date
Feb 9, 2009
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe